Medical device manufacturers today face unprecedented challenges in new business development as markets shift toward preventive devices, telemedicine, and medical IoT platforms. Traditional market research methods struggle to capture opportunities in these emerging domains, while regulatory complexity and the transition from product sales to subscription models create additional barriers to growth. We provide comprehensive consulting services that leverage proprietary AI tools and deep industry expertise to support medical device companies through the entire journey from theme exploration to sustainable commercialization, addressing these multifaceted challenges with proven methodologies and hands-on implementation support.
Business Development Challenges Facing Medical Device Manufacturers
Market Transformation Driven by Digital Health and Preventive Devices
The healthcare industry is experiencing a fundamental shift from treatment-focused care to prevention-oriented approaches, creating explosive demand for preventive devices and remote monitoring solutions. This transformation has intensified as AI diagnosis capabilities and medical IoT technologies reshape competitive landscapes, requiring medical device manufacturers to integrate software development and data analytics expertise with traditional device engineering. Theme exploration in these emerging markets presents unique difficulties because conventional research methodologies cannot adequately capture opportunities that don’t yet exist in clearly defined forms.
Medical device companies face particular challenges when attempting to cross the chasm from early adopters to mainstream healthcare providers in telemedicine and home medical care segments. While innovative clinicians may embrace new technologies despite incomplete evidence, the broader market demands proven clinical outcomes, seamless workflow integration, and clear economic value. Successfully navigating this transition requires sophisticated strategies that address not only technical requirements but also market education, reimbursement pathways, and organizational change management across diverse stakeholder groups.
Regulatory Complexity and Extended Time-to-Market Challenges
Balancing innovation speed with regulatory compliance requirements across multiple jurisdictions has become increasingly complex as manufacturers pursue global market opportunities. PoC validation requirements have grown more stringent for AI-enabled and connected devices, where software updates can continuously modify functionality and regulatory authorities demand ongoing monitoring systems. Business plan development becomes particularly challenging when regulatory timelines and reimbursement pathways remain uncertain, forcing difficult decisions about market sequencing and resource allocation.
Medical device manufacturers face resource allocation dilemmas between maintaining core business operations and investing in new business development initiatives with uncertain outcomes. Limited engineering resources, regulatory expertise, and management attention must be carefully distributed across competing priorities, requiring sophisticated planning that accounts for extended development cycles and evolving compliance requirements.
Business Model Evolution: From Product Sales to Subscription Services
Healthcare providers increasingly demand outcome-based pricing and subscription models rather than traditional capital equipment purchases, reflecting broader industry trends toward value-based care and operational flexibility. This shift creates significant challenges for medical device manufacturers as subscription models defer revenue recognition over contract terms, generating cash flow pressures during transition periods even while promising more predictable long-term revenue streams. Data monetization opportunities through medical IoT platforms offer attractive new revenue sources but require capabilities in data science, software development, and digital service delivery that extend beyond traditional manufacturing competencies.
Establishing recurring revenue streams while maintaining profitability proves difficult because subscription models typically involve lower per-transaction revenue than equipment sales, requiring larger customer bases and new capabilities in customer success management and churn prevention. Organizational resistance to business model transformation represents a significant internal challenge as sales teams, manufacturing operations, and finance departments must adapt to fundamentally different processes and success metrics.
ConnectaBlue’s New Business Development Support for Medical Device Manufacturers
End-to-End Support from Theme Exploration to Commercialization
We provide comprehensive support through the entire journey from market environment analysis to business theme identification using proprietary AI tools, followed by business plan formulation and hands-on implementation guidance. Our process begins with thorough industry trend research and competitive analysis that examines regulatory developments, customer needs, and market dynamics across multiple dimensions to identify opportunities aligned with your organization’s capabilities. This comprehensive analysis provides the foundation for informed theme exploration that considers not just current conditions but also emerging trends and future market potential.
Business plan development transforms validated themes into actionable roadmaps integrating differentiation strategies, market entry approaches, and financial projections that address all aspects of commercialization. We remain actively involved through implementation, providing hands-on business development support for PoC validation, customer development, partnership negotiations, and organizational structure construction. Progress management and PDCA cycle establishment create infrastructure for continuous improvement, ensuring initial plans evolve appropriately as market conditions change and new insights emerge through execution.
AI-Powered Business Theme Exploration Process
Our theme exploration process conducts thousands to tens of thousands of market trend and customer/competitor surveys using AI tools, providing unprecedented research breadth and depth that identifies patterns and opportunities impossible to detect through conventional methods. Comprehensive analysis identifies potential business opportunities in preventive devices, telemedicine, and medical IoT domains by synthesizing information from clinical literature, regulatory developments, competitive landscapes, and emerging technologies. For example, our analysis might reveal how demographic trends, healthcare cost pressures, regulatory changes, and technological advances converge to create specific opportunities in remote patient monitoring or home-based diagnostic solutions.
Detailed verification of marketability, competitiveness, and feasibility for promising themes employs focused research examining target customer segments, competitive offerings, regulatory pathways, reimbursement prospects, and implementation challenges. This rigorous evaluation process often reveals issues that would otherwise emerge only later in development, saving substantial time and resources by filtering out less viable concepts early. Materialization of selected ideas as concrete business models includes defining specific product concepts, value propositions, pricing strategies, distribution approaches, and development timelines that provide clear direction for implementation and investment decisions.
Business Creation Infrastructure Development for Sustainable Innovation
Successful new business development requires organizational infrastructure that systematically generates, evaluates, and commercializes innovations over time rather than pursuing isolated initiatives. We support process design for business creation and formulation of evaluation indicators that establish clear methodologies guiding how your organization identifies opportunities, assesses potential, develops plans, makes investment decisions, and manages implementation. Construction of decision-making mechanisms establishes governance structures balancing senior leadership oversight with team empowerment to move quickly and adapt to market feedback.
Human resource development planning addresses the challenge of building teams with diverse skills necessary for medical device business development, including clinical knowledge, regulatory expertise, technical capabilities, and market understanding. We also propose development of IT, finance, and marketing infrastructure necessary for business expansion, creating comprehensive support systems that enable sustainable growth. Through cultivating organizational culture that nurtures new business seeds through commercialization, we help establish capabilities for ongoing innovation as a core strategic competency rather than occasional activity.
ConnectaBlue’s Approach to Medical Device Industry-Specific Challenges
Accelerating PoC Validation and Crossing the Chasm in Digital Health Markets
We provide structured PoC verification methodologies specifically designed for AI diagnosis and medical IoT solutions, establishing clear validation frameworks that satisfy both clinical requirements and business case development needs. Our customer development strategies leverage proprietary web marketing methods to identify early adopters and understand their specific needs, enabling targeted engagement that accelerates initial market traction. Evidence generation frameworks help medical device companies build the clinical validation and economic justification necessary for mainstream market adoption.
Crossing the chasm in telemedicine and home medical care segments requires understanding adoption patterns unique to these markets, where workflow integration, user experience, and support infrastructure become critical success factors beyond core device functionality. We develop chasm-crossing tactics that address the distinct concerns of mainstream healthcare providers, including integration complexity, staff training requirements, and return on investment demonstration. This approach helps companies transition from successful pilots with enthusiastic early adopters to scalable commercial operations serving the broader market.
Subscription Model Design and Recurring Revenue Strategy
We support business model transformation from capital equipment sales to subscription-based service offerings, helping medical device manufacturers navigate the strategic and operational changes this transition requires. Pricing strategy development for outcome-based contracts and data-enabled services addresses the complex challenge of value quantification in subscription contexts, where pricing must reflect ongoing value delivery rather than one-time product transfer. Financial modeling accounts for transition period cash flow challenges, ensuring companies maintain financial stability while building recurring revenue streams.
Customer success infrastructure design ensures retention and expansion in subscription models by establishing proactive engagement processes, value demonstration mechanisms, and expansion selling approaches. Our business plan development for subscription models integrates all these elements into comprehensive strategies that manage transition risks while capturing long-term revenue opportunities. This holistic approach addresses not just pricing and contracts but also organizational capabilities, technology systems, and customer relationship management processes essential for subscription business success.
Regulatory-Aware Business Planning and Market Entry Strategy
Our business plan development integrates regulatory pathway analysis and timeline projections, ensuring commercialization strategies account for approval requirements and compliance complexities from the outset. Multi-jurisdictional market entry sequencing optimizes the order in which companies pursue different geographic markets based on regulatory complexity, market attractiveness, and strategic fit. This sequenced approach manages resource requirements while building momentum through early market successes that validate the business model and generate revenue supporting subsequent expansions.
Risk mitigation strategies for theme exploration in highly regulated preventive device and AI diagnosis domains help companies pursue innovation while managing uncertainty about regulatory requirements and approval timelines. We develop reimbursement strategy formulation aligned with evolving healthcare payment models, recognizing that regulatory approval alone does not ensure commercial success without adequate coverage and payment. This comprehensive approach to regulatory and reimbursement planning ensures business plans reflect realistic pathways to market access and revenue generation rather than optimistic assumptions that may prove unfounded.
4. Three Distinctive Features of ConnectaBlue’s Medical Device Consulting Services
4.1 Extensive Track Record in Industrial Fields Requiring Advanced Expertise
We excel in new business development support not only in IT fields but also in industrial sectors including materials, chemicals, processing technologies, and medical devices. Our consultants bring deep expertise in these technically complex domains where theme exploration requires understanding both advanced technologies and market dynamics. By combining this domain knowledge with systematic business development methodologies, we help clients identify opportunities that others overlook.
Our proprietary AI tools enable large-scale specialized surveys and estimations at unprecedented speed. We conduct thousands to tens of thousands of market scans, competitive analyses, and opportunity assessments that would be impractical using conventional consulting business approaches. This comprehensive research capability allows us to materialize commercialization themes and market entry scenarios with high accuracy, presenting optimal options for our clients.
The business strategies we develop combine AI-generated insights with our consultants’ empirical knowledge and advanced know-how. Through vigorous discussions with clients, we create new business plans that are simultaneously novel, feasible, and highly convincing to internal stakeholders and potential partners. This integration of technology-enabled research and human expertise delivers results that neither approach could achieve independently.
4.2 Proprietary AI Tools and Know-How for Comprehensive Theme Exploration
Our distinctive approach to theme exploration leverages multiple generative AI tools, each optimized for different research and estimation tasks. We have developed proprietary methodologies that combine these tools strategically, dramatically improving the materialization level and accuracy of AI-based market research. This multi-tool approach allows us to validate findings across different AI systems, reducing the risk of bias or error inherent in relying on a single platform.
We possess AI prompt templates specifically optimized for new business theme exploration in medical device contexts and other industrial sectors. These templates encode our accumulated consulting expertise, enabling systematic execution of research processes that would traditionally require extensive manual effort. Our tools can conduct tens of thousands of surveys and estimations in short periods, creating comprehensive market views impossible to achieve through conventional methods.
This capability proves particularly valuable when exploring opportunities in preventive devices, telemedicine, AI diagnosis, and medical IoT domains where traditional market research struggles to provide reliable guidance. Regardless of industry or theme, our AI-powered approach enables objective and comprehensive business development that escapes the limitations of person-dependent methods such as idea contests and workshops. Clients gain confidence in pursuing new ventures based on systematic evidence rather than intuition alone.
4.3 Needs Exploration and Customer Development Leveraging Web Marketing Methods
We visualize latent needs in preventive devices, home medical care, and other emerging medical device segments through proprietary web data analysis. Our methods extract insights from user search behavior, browsing patterns, and digital footprints that reveal the “true feelings” and “signs” that conventional market research and questionnaires cannot capture. This data-driven approach uncovers unmet needs before they become obvious to competitors.
By analyzing these digital signals, we identify market gaps that existing businesses overlook and demand trends expected to expand in the future. For medical device manufacturers exploring new business opportunities, understanding these latent needs proves essential for developing products and services that resonate with target markets. Our web marketing expertise complements traditional research methods, providing a more complete picture of market opportunities.
Through approaches that do not rely solely on intuition or empirical rules, we objectively evaluate new business directions and scientifically derive opportunities with high success probability. This methodology increases precision of investment decisions, helping clients allocate resources to ventures most likely to achieve commercial success. The combination of AI-powered theme exploration and web-based needs analysis creates a powerful foundation for business development in uncertain markets.
5. Case Studies: Medical Device Manufacturers’ New Business Success Stories
5.1 Medical Device Manufacturer’s Entry into Preventive Healthcare Field
A medical device manufacturer sought to leverage proprietary technology to expand beyond traditional treatment devices into the growing prevention market. The company recognized opportunities in preventive devices and remote monitoring but lacked clarity on specific market segments to target and business models to pursue. Theme exploration using our AI tools identified promising opportunities in subscription-based remote monitoring services for chronic disease management.
We conducted comprehensive theme exploration, analyzing thousands of market trends and competitive scenarios to identify the most viable entry points. Following opportunity identification, we supported PoC validation with early adopter healthcare providers and developed a detailed business plan covering regulatory strategy, reimbursement approach, and commercial operations. Our support extended through the critical phase of crossing the chasm from pilot projects to mainstream adoption.
The manufacturer successfully entered the new market with a subscription-based service that generated recurring revenue from day one. The business achieved early profitability within the planned timeframe and successfully transitioned from serving innovative early adopters to mainstream healthcare providers. This new business now represents a significant growth engine, diversifying the company’s revenue streams and positioning it advantageously in the shift toward preventive healthcare.
5.2 Pharmaceutical Manufacturer’s Peripheral Business Development
A pharmaceutical manufacturer aimed to diversify revenue streams by developing medical device business leveraging drug discovery technology and knowledge. The company possessed deep expertise in specific therapeutic areas but lacked experience in medical device development, regulatory pathways, and commercialization. We provided comprehensive support from market research in medical IoT and AI diagnosis domains to commercialization strategy formulation.
Our team conducted extensive research to identify where the client’s pharmaceutical expertise could create differentiation in medical device markets. We developed a business plan that addressed the unique regulatory considerations of combination products and device-drug ecosystems. The strategy positioned the new business to leverage existing relationships with healthcare providers while building new commercial capabilities appropriate for device markets.
The manufacturer successfully established a new business pillar with clearly differentiated positioning in the market. The venture navigated complex regulatory requirements successfully and built a sustainable growth trajectory. This diversification reduced dependence on pharmaceutical revenues while creating synergies with the core business through shared customer relationships and complementary product offerings.
5.3 Precision Equipment Manufacturer’s IoT Solution Business Launch
A precision equipment manufacturer sought to transition from capital equipment sales to subscription-based service models using proprietary measurement technology. The company recognized that its sensing capabilities could enable valuable telemedicine applications and remote monitoring services but lacked expertise in subscription business models, software development, and healthcare market dynamics. We provided business model transformation support including subscription pricing strategy, customer development, and organizational structure construction.
Our consulting team helped the manufacturer design a subscription offering that aligned pricing with customer value realization while maintaining healthy unit economics. We supported customer development efforts to identify early adopters willing to pilot the new service and provide feedback for refinement. The implementation included establishing recurring revenue management systems, customer success processes, and organizational structures appropriate for ongoing service delivery rather than transactional sales.
The manufacturer successfully launched an IoT solution business that leverages its core sensing technology in new applications. The subscription model established a recurring revenue stream that improved revenue predictability and increased customer lifetime value. The business expanded customer touchpoints beyond equipment sales to ongoing service relationships, strengthening competitive positioning and creating barriers to competitor displacement. The success of this venture positioned the company to pursue additional platform opportunities building on the IoT infrastructure.
6. About ConnectaBlue: Consulting Firm Delivering Unique Results Through Exceptional Capabilities
6.1 ConnectaBlue’s Organizational Capabilities and Global Network
We are a consulting firm that delivers unique results and experiential value through exceptional individual capabilities and proprietary data and approaches. Our organization comprises professionals from top consulting firms, bringing world-class expertise to every client engagement. This foundation of individual excellence combines with systematic methodologies and innovative tools to create consulting services that consistently exceed client expectations.
We maintain a global network of over 500 consultants, enabling comprehensive support across all industries and themes. This network provides access to specialized expertise precisely when clients need it, without the overhead of maintaining large permanent staff. For medical device manufacturers pursuing new business development, this means access to consultants with specific experience in relevant therapeutic areas, regulatory domains, market segments, and business models.
Our client base spans companies with sales from 10 billion yen to over 1 trillion yen, across diverse industries and organizational contexts. We have received high acclaim from customers for providing speedier and higher quality services than major firms. This reputation reflects our ability to combine the agility and responsiveness of a specialized firm with the capabilities and rigor traditionally associated with large consulting organizations.
6.2 Specialized Expertise in New Business Development and Industrial Sectors
We boast an overwhelming track record in BtoB marketing, new business development, and R&D support within the consulting business landscape. Our expertise in theme exploration, business plan formulation, and business development support has helped numerous clients successfully launch and scale new ventures. We understand the unique challenges of developing new businesses in industrial contexts where long sales cycles, technical complexity, and relationship-based selling require specialized approaches.
Our excellence in industrial fields including materials, chemicals, processing technologies, and medical devices distinguishes us from generalist consulting firms. We understand the technical, regulatory, and market dynamics of these sectors, enabling us to provide guidance grounded in industry reality rather than generic frameworks. This domain expertise proves particularly valuable during theme exploration and business plan development, where understanding industry-specific constraints and opportunities directly impacts strategy quality.
We accelerate client business growth through AI tools and digital marketing methodologies that complement traditional consulting approaches. Our proprietary capabilities in web-based needs exploration, AI-powered market research, and data-driven opportunity evaluation provide clients with insights and options they would not discover through conventional methods. These capabilities, combined with our consultants’ expertise, create a powerful platform for new business development in medical devices and other industrial sectors.
6.3 Service Focus and Engagement Approach
Our services focus on business theme exploration, business plan formulation, business development support, and business creation infrastructure development. This comprehensive scope allows us to support clients throughout the entire new business lifecycle, from initial opportunity identification through successful commercialization and scaling. We tailor our engagement approach to each client’s specific needs, providing exactly the support required at each stage of business development.
For medical device manufacturers seeking new business development support, we offer specialized expertise in navigating regulatory complexity, developing subscription and platform business models, and crossing the chasm from early adopters to mainstream markets. Our understanding of healthcare market dynamics, reimbursement strategies, and clinical evidence requirements enables us to help clients develop strategies that address the full complexity of medical device commercialization.
We welcome consultation from medical device manufacturers exploring opportunities in preventive devices, telemedicine, AI diagnosis, medical IoT, and other emerging segments. Our team brings the industry knowledge, methodological rigor, and innovative tools necessary to help you identify promising opportunities, develop compelling business plans, and successfully implement new ventures that drive sustainable growth. We look forward to partnering with you to create the future of your business.
FAQ
What is new business consulting for medical device manufacturers?
New business consulting for medical device manufacturers is a form of bizdev consulting where we support you in business development, from discovering new business opportunities to shaping a realistic business plan. We listen carefully to your specific needs and long term objectives so that we can determine suitable markets, services, and partnership models while being passionate about patient and clinician value.
How does your consulting business support medical device business development?
We operate as a consulting business focused on medical devices, supporting business development by analyzing clinical needs, regulations, and reimbursement. Through our consulting practice we clarify your target market, refine product–market fit, and prioritize projects. Our team also provides guidance on implementing commercialization roadmaps and building relationships with KOLs, distributors, and hospital systems for sustainable growth.
What are the main benefits of hiring consultants for industry growth?
By working with consultants who specialize in the medical device industry, companies gain structured insights, proven practices, and faster decision making. We help you determine growth scenarios, reduce regulatory and market risks, and focus resources where they matter most. Many clients also value that external consultants facilitate cross‑functional alignment among R&D, quality, and sales departments, supporting smoother execution and higher profitability.
How do you help manufacturers develop new business strategies?
To develop effective new business strategies, we start with in‑depth research on clinical workflows, competing technologies, and reimbursement systems. Together with your employees we clarify objectives, then create market entry and channel strategies. We support scenario planning, revenue modelling, and risk management, and we stay involved during implementation so the strategy translates into concrete actions in sales, marketing, and development teams.
What services do you provide as part of new business consulting?
Our services span market assessment, opportunity sizing, portfolio strategy, and business model creation. We also design commercialization plans, support product–market fit validation, and advise on pricing, reimbursement, and sales channel structure. In addition, we help manage cross‑border projects, coordinate partners such as distributors or OEMs, and provide coaching to internal project owners so they can continue the development journey with confidence.
How do you help identify and prioritize target markets?
We identify your target market by combining quantitative data and field interviews with clinicians, purchasing departments, and payers. We compare procedure volumes, competitive intensity, and regulatory hurdles across regions, then determine where your technology has the strongest value proposition. This structured process clarifies which specialties, indications, and countries should come first, enabling you to focus investments on the markets with the best risk–return balance.
What is your process for implementing business development plans?
After agreeing on a plan, we translate it into a phased implementation roadmap with milestones, KPIs, and responsible owners. We support implementing pilot launches, channel tests, and pricing validation in selected markets, then refine the plan based on evidence. Our consultants help you manage cross‑functional coordination, track risks, and adapt to regulatory or reimbursement changes, so business development activities stay aligned with corporate priorities and resources.
How do you support market research and international expansion?
We conduct market research through data analysis and interviews with clinicians, distributors, and payers to understand adoption drivers and barriers. For companies planning to expand overseas, we map local regulations, reimbursement pathways, and competitive landscapes. Based on this, we create step‑by‑step expansion scenarios, including partner selection criteria, channel options, and project timelines, helping you reduce uncertainty when entering unfamiliar regions.
What kind of expertise do your consultants have?
Our consultants bring expertise from medical device manufacturers, hospitals, and global consulting firms. Backgrounds include regulatory affairs, clinical development, product management, and sales. Many have hands‑on experience launching devices in multiple regions. This mix of strategic and operational knowledge enables us to advise on topics ranging from concept validation and pre‑clinical strategy to reimbursement, sales force design, and post‑market evidence generation.
How can medical device entrepreneurs achieve success through consulting support?
For entrepreneurs launching innovative devices, we help articulate the clinical problem, refine the solution, and shape a staged development and commercialization plan. We support funding narratives, including how to use money efficiently across R&D, trials, and launch. By clarifying value for clinicians, hospitals, and payers, and by prioritizing early adopter segments, entrepreneurs can move toward success while managing risks and protecting long term growth potential.
How do you approach client engagements with medical device companies?
In client engagements we begin with careful listening to your challenges, then jointly frame hypotheses. We work transparently, sharing assumptions, data sources, and decision criteria. Regular touchpoints keep your project team involved, and interim outputs are refined based on feedback. This approach builds trust, supports internal alignment, and ensures that recommendations are practical for your organization’s culture, systems, and resource constraints.
Can you work with independent consultant teams inside our organization?
Some clients have an internal independent consultant or strategic planning unit. We are comfortable collaborating with such teams, sharing methods, research tools, and templates. Our role can range from providing an external viewpoint to co‑developing frameworks that your internal team will later own. This collaborative style strengthens your internal capabilities while benefiting from our outside‑in perspective on the global medical device industry.
How do you support building relationships with key partners and customers?
We help identify stakeholders who are critical for adoption, such as KOLs, early adopter hospitals, distributors, and payers. Together we map decision processes and interests on each side, then design engagement plans. This can include advisory boards, pilot projects, and structured feedback sessions. Our focus is on building relationships that create mutual value and support long term collaboration rather than relying only on short‑term transactions.
What role do digital tools such as email campaigns and LinkedIn play?
For B2B medical device marketing, we sometimes advise on digital tactics such as targeted email campaigns or optimizing your linkedin profile for key team members. While we are not an advertising agency, we can help clarify messages, audiences, and content themes that align with your clinical evidence and strategic goals. Digital touchpoints support awareness building among potential clients, but we always integrate them into a broader go‑to‑market plan.
How are consulting fees structured in this field?
Typical market rates vary widely. Strategy firms often start from around 20 million yen per month, comprehensive firms from around 10 million yen per month, and mid‑sized firms from around 4 million yen per month. Our own fee proposals consider project scope, required specialist skills, and duration. In some cases phased projects can help balance budget constraints and risk while preserving value for both your organization and our team.
Can consulting really justify higher fees compared with internal projects?
Whether higher fees are justified depends on the complexity of your challenge and the value of external insights. For example, entering a new therapeutic area or region can carry significant regulatory and market risk. Experienced consultants bring structured methods, cross‑company benchmarks, and lessons learned from previous projects. Many clients feel that avoiding one major misstep or delay often offsets consulting costs over the product’s lifecycle.
How do you handle confidentiality and contract arrangements?
We usually begin with a mutual non‑disclosure agreement, then move to a detailed contract covering scope, timelines, deliverables, and governance. Intellectual property arrangements are discussed transparently, particularly when we contribute to creation of new concepts or frameworks. We also clarify communication rules and decision rights in advance to avoid misunderstandings and to protect both your company and our consulting team throughout the engagement.
Do you support internal capability development for business development teams?
Yes, part of our mission is to strengthen your internal business development and marketing capabilities. During projects we share tools, templates, and practices for market assessment, portfolio decisions, and launch planning. We often involve your employees in interviews and analysis so skills transfer naturally. Over time, your team can manage similar initiatives independently, while calling on us only for highly specialized or cross‑border topics.
How do you work with different departments such as R&D and quality?
Medical device strategy affects multiple functions. We coordinate with R&D, clinical, regulatory, quality, manufacturing, and sales departments so that market and development perspectives are aligned. For example, clinical evidence plans must reflect payer expectations, and design choices must match target workflows. By connecting departments early, we reduce rework, support efficient use of resources, and keep everyone focused on shared business goals.
Can you give an example of how you support creation of a business plan?
In a typical example, we first size the market and identify priority segments, then model adoption curves and pricing to estimate revenue and profit potential. Next we map required investments in R&D, trials, and commercialization. Together with your finance and marketing teams, we transform these assumptions into a structured business plan, including milestones, risk scenarios, and key indicators that management can monitor over the product’s lifecycle.
How do you help manage risks related to regulation and insurance coverage?
Regulation and insurance reimbursement heavily influence device adoption. We work with regulatory and health‑economics specialists to understand classification, approval pathways, and evidence expectations. Then we align clinical study design, health‑economic models, and price positioning with payer requirements. By integrating these elements early into development and go‑to‑market planning, companies can manage approval and coverage risks more effectively.
Do you also advise on organization design and hiring for growth?
When business development leads to new regions or product lines, organization structures and staffing often need to adapt. We help clarify key roles, reporting lines, and decision rights. In collaboration with HR, we define profiles for hiring, especially for commercial and market access roles. While recruitment itself is handled by your company or agencies, our input supports coherent organization design to execute your strategy efficiently.
How do you support projects related to new digital or connected technologies?
Digital and connected devices introduce additional considerations such as cybersecurity, data privacy, and software life‑cycle management. We help assess market readiness, stakeholder expectations, and required technology partnerships. Together we plan development roadmaps, go‑to‑market strategies, and service models that fit hospital IT environments. Our goal is to balance innovation with practicality so that advanced technology translates into real clinical and business value.
What should we prepare before engaging your consulting services?
It is helpful to gather basic information such as product descriptions, existing research, regulatory status, and internal plans or presentations. Clarifying your main questions and constraints—timing, budget, territories—also accelerates the project start. However, we understand that some of this may still be evolving, especially in early‑stage development, and we are accustomed to helping clients frame and refine their questions during initial discussions.
How do you support the creation and management of long term development roadmaps?
We work with you to create portfolio roadmaps that connect clinical trends, technology evolution, and competitive moves. These roadmaps usually span several years and outline platform development, line extensions, and regional roll‑outs. We then help define review cycles, metrics, and governance so the roadmap is updated as evidence and market conditions change. This discipline supports long term alignment between strategy, investment, and execution.
Can your consulting support be useful for smaller companies and start‑ups?
Smaller companies often face constraints in money, people, and time, while navigating complex regulatory and clinical environments. Our experience with entrepreneurs and mid‑sized manufacturers enables us to tailor scope and depth to what is feasible. We focus on the most critical decisions—such as indication selection, target market choice, and partnering approach—so that limited resources are concentrated where they most affect future growth and valuation.
Do you help evaluate and manage partnerships with external companies?
Yes, partnerships with distributors, OEMs, or technology providers are common in medical devices. We support partner screening, evaluation of strategic fit, and scenario design for cooperation models. During negotiations we help clarify roles, responsibilities, and performance metrics. After agreements are signed, we can support governance design so both sides have clear expectations, review mechanisms, and escalation paths for a healthy, long term partnership.
How do you ensure your advice aligns with our corporate culture and practices?
Each organization has its own decision style, risk tolerance, and communication norms. Early in our engagement we invest time in understanding your culture and existing practices. We involve key employees from different levels, and we test small steps before recommending large changes. Our aim is to provide rigorous analysis while respecting how your company works, so that recommendations are realistic and can be adopted without unnecessary friction.
Is your consulting support also helpful for internal consulting or strategy teams?
Many larger manufacturers have internal strategy or business development teams. We frequently work alongside them, sharing market insights, benchmarks, and frameworks, or covering regions and technologies they cannot fully research. In some cases we take on discrete modules such as pricing, market access, or competitor analysis. This collaborative mode allows internal teams to stay in the driver’s seat while leveraging our external experience where needed.
Can insights from your projects be used to improve future client engagements?
Yes, we constantly refine our methods based on lessons from previous projects, though we strictly protect client confidentiality. General insights about market dynamics, adoption patterns, or regulatory trends become part of our internal knowledge base. This cumulative learning enables us to start each new project more quickly and to suggest options that have worked in similar contexts, improving both efficiency and the quality of our recommendations.
How do you balance short‑term project results with long term business goals?
We recognize that you may need near‑term milestones, such as fundraising or board approvals, while also protecting long term potential. When designing plans, we distinguish between quick wins and foundational investments. For example, pilot projects might validate adoption in one segment, while underlying technology platforms are developed for broader indications. This balance supports immediate decisions without locking you into unfavorable paths later.
Do you support individuals running their own consulting business in this field?
Occasionally we collaborate with individuals who operate their own consulting business in adjacent niches, such as regulatory or clinical trial management. In such cases we coordinate roles clearly so the client receives integrated support. Our focus remains on strategic and commercial aspects, while partners may cover specialized domains. This model can be helpful when a project needs both broad business perspectives and very focused specialist expertise.